Pharma BD Deal Intelligence

MedImmune Inc. / Aviron

2001 · Acquisition/Merger · $1.5B · Complete

Announcement Sentiment
83
Strongly positive

MedImmune-Aviron stock-for-stock deal; 1.075 MedImmune shares per Aviron share at $47.41/share. Brought in FluMist intranasal flu vaccine. Closed 2002-01-10.

Key facts

See the full interactive analysis, sources & comparables →